|
|
|
|
|
|
|
|
Full Text
Background
Serum levels of CA125 measured
before any treatment have been evaluated in epithelial ovarian cancer
(EOC) as a predictor of patient survival; however, results in survival
index are controversial, as CA125 levels are influenced by several
variables. Taking this into consideration, the present study evaluated
the association of pretreatment levels of CA125 serum with the clinical
stage, histology and differentiation grade of the tumor and the survival
rate in a group of patients from an oncology referral center in Mexico,
all of them diagnosed with ovarian carcinoma.
This retrospective study
consisted of 1009 patients with EOC, diagnosed between 2006 and 2013 at
the National Cancerology Institute (Instituto Nacional de
Cancerología-INCan), considering only those with CA125 measurements
before any chemotherapy or surgical cytoreduction......
Patients were referred from the whole country, mainly from the central region of Mexico. The educational level of the patients was elementary in three of four. The median age of the study population was 51, ranging from 18 to 90 years old; 60 % of the patients were aged 41–60 years. The mean body mass index of the patients was 26.8 Kg/m2, with 60 % of them undergoing menopause.The following proportions of histological subtypes were observed in epithelial ovarian cancer patients (n = 1009): serous 55 %, endometrioid 19 %, mucinous 8 %, clear cells 8 %, and mixed carcinoma 10 %. The clinical stages of the patients were stage III (42 %), stage IV (36 %) whereas stages I and II represented the remaining 22 %.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.